Avon Lifesciences Ltd SHARE PRICE [LIVE]

  
NSE: AVONLIFE
N/A
BSE: 531541
4.70
To view real time prices Login to your account
OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality

Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Not Applicable
Sector
4.63%
Sensex
10.2%
IndustryChemicals
MARKET CAP (Micro Cap Stock)Rs Cr
PE (TTM) 0.00
DIVIDEND YIELD 0.00%
PE Ratio-0.72
Price to Book Value-0.09
EV to EBIT-10.03
EV to EBITDA-14.44
EV to Capital Employed8.35
EV to Sales
PEG Ratio0.00
Dividend YieldNA
ROCE (Latest)-83.20%
ROE (Latest)Negative BV
NameSep 22Jun 22
Promoters (Change:0.00) 44.95%44.95%
FIIs (Change:0.00) 0%0%
Mutual Funds (Change:0.00) 0%0%
Insurance Companies (Change:0.00) 0%0%
Other DIIs (Change:0.00) 0.66%0.66%
Non Institution (Change:0.00) 54.39%54.39%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Avon Lifesciences Ltd

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

AVONLIFE News

Frequently Asked Questions

What is the Share price of Avon Lifesciences Ltd (AVONLIFE)?

Avon Lifesciences Ltd (AVONLIFE) share price as of December 6, 2022, on BSE is Rs 4.70 (BSE).

Can I buy Avon Lifesciences Ltd (AVONLIFE) shares?

Yes, You can buy Avon Lifesciences Ltd (AVONLIFE) shares by opening a Demat account with Angel One.

How do I buy Avon Lifesciences Ltd (AVONLIFE) from Angel One?

Avon Lifesciences Ltd (AVONLIFE) share can be brought through the following modes:
  1. Direct investment: You can buy Avon Lifesciences Ltd (AVONLIFE) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Avon Lifesciences Ltd (AVONLIFE) shares.

In which sector do Avon Lifesciences Ltd (AVONLIFE) belong?

Avon Lifesciences Ltd (AVONLIFE) belongs to Chemicals.

About AVONLIFE

Today's live share price for Avon Lifesciences Ltd is NSE: N/A, BSE: ₹ 4.70 with a current market capitalization of .

Avon Organics, promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu was incorporated in August 1993 to manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US. XTP shall be the technical supervisor for the transfer of technology, while SMEC shall supply the technical knowhow. The company has bagged the award for the Best New Product manufactured in the State of Andhra Pradesh as awarded by the Federation of Andhra Pradesh Chamber of Commerce and Industry and also certified as an ISO 9002 company by American Quality Asseassors accredited with ANSI-RAB for the manufacturing and marketing MMAA, MMAE, DEA, EEAA and Aralydes. The company had developed technology for recovery of Diketene from sludge. The company has also diversified into Bio-Technology, where the value addition is high. To part finance its biotech project the company has made a preferential issue of 1800000 Equity shares at Rs. 38.75 each aggregating to Rs. 697.50 lacs and issued 400000 warrants convertible into 400000 equity shares during the year 1999-2000. The Bio-Technology Plant is located at Solapur,Maharashtra for manufacture of Ephedrine and Pseudo-Ephedrine with an installed capacity of 150 MT p.a. The plant has commenced operations during April 2001. The biotech division produces Pharmaceutical intermediates i.e Pseudoephedrine and ephedrine. The company has signed two longterm export contracts to supply fixed quantities of Pseudoephedrine and is in talks with a few more MNC's for long term contracts during the year 2001-02. The company's bio-tech division is pursuing USFD approval which will enable it to enter into regulated markets. The company is all set to introduce two high value added intermediates in its Diketene division.The company has already completed trial production for these two pharmaceutical products and is ready for commercial launch.The company is expected an additional turnover of Rs.12 crores from these products from the year 2005-06.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers